As of 2025-10-20, the EV/EBITDA ratio of Guardant Health Inc (GH) is -25.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GH's latest enterprise value is 8,649.90 mil USD. GH's TTM EBITDA according to its financial statements is -345.80 mil USD. Dividing these 2 quantities gives us the above GH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 12.2x | 9.8x |
| Forward P/E multiples | 7.7x - 15.7x | 10.0x |
| Fair Price | (26.58) - (37.62) | (31.42) |
| Upside | -140.6% - -157.5% | -148.0% |
| Date | EV/EBITDA |
| 2025-10-17 | -25.01 |
| 2025-10-16 | -25.74 |
| 2025-10-15 | -24.56 |
| 2025-10-14 | -23.97 |
| 2025-10-13 | -23.67 |
| 2025-10-10 | -24.57 |
| 2025-10-09 | -24.94 |
| 2025-10-08 | -24.96 |
| 2025-10-07 | -24.29 |
| 2025-10-06 | -24.26 |
| 2025-10-03 | -24.07 |
| 2025-10-02 | -23.57 |
| 2025-10-01 | -24.00 |
| 2025-09-30 | -23.94 |
| 2025-09-29 | -23.76 |
| 2025-09-26 | -23.06 |
| 2025-09-25 | -23.11 |
| 2025-09-24 | -22.21 |
| 2025-09-23 | -22.94 |
| 2025-09-22 | -22.97 |
| 2025-09-19 | -22.74 |
| 2025-09-18 | -22.61 |
| 2025-09-17 | -22.03 |
| 2025-09-16 | -21.39 |
| 2025-09-15 | -21.17 |
| 2025-09-12 | -21.20 |
| 2025-09-11 | -21.89 |
| 2025-09-10 | -21.81 |
| 2025-09-09 | -22.84 |
| 2025-09-08 | -23.10 |
| 2025-09-05 | -23.09 |
| 2025-09-04 | -23.54 |
| 2025-09-03 | -24.87 |
| 2025-09-02 | -25.39 |
| 2025-08-29 | -25.72 |
| 2025-08-28 | -24.66 |
| 2025-08-27 | -24.31 |
| 2025-08-26 | -24.28 |
| 2025-08-25 | -23.72 |
| 2025-08-22 | -23.55 |
| 2025-08-21 | -23.51 |
| 2025-08-20 | -22.50 |
| 2025-08-19 | -22.53 |
| 2025-08-18 | -22.85 |
| 2025-08-15 | -22.64 |
| 2025-08-14 | -23.18 |
| 2025-08-13 | -22.53 |
| 2025-08-12 | -21.28 |
| 2025-08-11 | -21.17 |
| 2025-08-08 | -20.96 |